文献速递糖尿病

高脂喂养的脑啡肽酶缺陷小鼠血糖改善与DPP-4活性降低及活性GLP-1水平升高相关

Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.
PubMed 文献 · Diabetologia · 2016-12-08

研究在高脂喂养小鼠模型中比较脑啡肽酶缺陷(Nep -/-)与野生型(Nep +/+)小鼠,发现Nep -/-小鼠活性GLP-1升高、血浆DPP-4活性降低,并伴糖耐量、胰岛素敏感性和β细胞功能改善,胰岛素清除无差异。作者认为脑啡肽酶抑制可能是2型糖尿病的新治疗策略。

要点

  • 高脂喂养Nep -/-小鼠活性GLP-1为5.8 ± 1.1 pmol/l,高于Nep +/+的3.5 ± 0.8 pmol/l(p < 0.05)。
  • 高脂喂养Nep -/-小鼠血浆DPP-4活性为7.4 ± 1.0 nmol ml-1 min-1,低于Nep +/+的10.7 ± 1.3 nmol ml-1 min-1(p < 0.05)。
  • Nep -/-与Nep +/+小鼠胰岛素:C肽比值无差异,提示血糖改善并非源于胰岛素清除改变。

核心结论

  • 在膳食脂肪增加条件下,脑啡肽酶缺陷小鼠的血糖状态改善与活性GLP-1水平升高、血浆DPP-4活性降低及β细胞功能改善相关。
  • 作者认为脑啡肽酶抑制可能是2型糖尿病的一种新治疗策略。

研究设计与样本

  • 研究将Nep +/+与Nep -/-小鼠以60%脂肪饮食喂养16周,随后测定活性GLP-1与DPP-4活性,并在口服葡萄糖耐量试验(OGTT)中测定葡萄糖、胰岛素和C肽水平。
  • 胰岛素敏感性通过胰岛素耐量试验评估。

主要发现

  • 高脂喂养Nep -/-小鼠活性GLP-1水平为5.8 ± 1.1 pmol/l,高于高脂喂养Nep +/+小鼠的3.5 ± 0.8 pmol/l(p < 0.05)。
  • 高脂喂养Nep -/-小鼠血浆DPP-4活性为7.4 ± 1.0 nmol ml-1 min-1,低于高脂喂养Nep +/+小鼠的10.7 ± 1.3 nmol ml-1 min-1(p < 0.05)。
  • 与高脂喂养Nep +/+小鼠相比,高脂喂养Nep -/-小鼠糖耐量、胰岛素敏感性和β细胞功能改善。
  • Nep -/-与Nep +/+小鼠之间胰岛素:C肽比值无差异,提示血糖改善并非源于胰岛素清除改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM/HYPOTHESIS: Neprilysin, a widely expressed peptidase, is upregulated in metabolically altered states such as obesity and type 2 diabetes. Like dipeptidyl peptidase-4 (DPP-4), neprilysin can degrade and inactivate the insulinotropic peptide glucagon-like peptide-1 (GLP-1). Thus, we investigated whether neprilysin deficiency enhances active GLP-1 levels and improves glycaemia in a mouse model of high fat feeding. METHODS: Nep +/+ and Nep -/- mice were fed a 60% fat diet for 16 weeks, after which active GLP-1 and DPP-4 activity levels were measured, as were glucose, insulin and C-peptide levels during an OGTT. Insulin sensitivity was assessed using an insulin tolerance test. RESULTS: High-fat-fed Nep -/- mice exhibited elevated active GLP-1 levels (5.8 ± 1.1 vs 3.5 ± 0.8 pmol/l, p < 0.05) in association with improved glucose tolerance, insulin sensitivity and beta cell function compared with high-fat-fed Nep +/+ mice. In addition, plasma DPP-4 activity was lower in high-fat-fed Nep -/- mice (7.4 ± 1.0 vs 10.7 ± 1.3 nmol ml-1 min-1, p < 0.05). No difference in insulin:C-peptide ratio was observed between Nep -/- and Nep +/+ mice, suggesting that improved glycaemia does not result from changes in insulin clearance. CONCLUSIONS/INTERPRETATION: Under conditions of increased dietary fat, an improved glycaemic status in neprilysin-deficient mice is associated with elevated active GLP-1 levels, reduced plasma DPP-4 activity and improved beta cell function. Thus, neprilysin inhibition may be a novel treatment strategy for type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Willard JR, Barrow BM, Zraika S, et al. Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels. Diabetologia. 2016. PMID: 27933334. doi:10.1007/s00125-016-4172-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。